Grail completed its spinoff from San Diego biotech giant Illumina in June.The layoffs come after a “portfolio review” at Grail, according to Rowland, which sparked the company to devote more ...

GRAIL, Inc. (NASDAQ:GRAL), a biotechnology company based in Menlo Park, California, was originally a startup and former subsidiary of Illumina. It focuses on developing early cancer screening ...

Among biotech stocks, few other companies have the ... Last month, the company spun off its cancer testing acquisition, Grail (NASDAQ:GRAL) which had been the center of significant controversy ...

Grail is an American biotechnology company that develops an early screening test for the detection of cancer without visible symptoms. The headquarters is located in Menlo Park (California) with ...

Grail Inc, an American biotechnology company, developed an early-detection blood test called Galleri, created to identify more than 50 types of cancer before symptoms appear, per Reuters.

Volunteers aged between 50 and 77 are being sought to trial the diagnostic developed by California biotech Grail, which spun out of Illumina in 2016 and agreed to be reacquired by the lab ...

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news: Sollis Health is a membership-based concierge emergency-care startup in New York. It announced ...